This site is intended for healthcare professionals
News

Phase III SEAL study of Xpovio shows efficacy in liposarcoma.- Karyopharm Therapeutics

Read time: 1 mins
Last updated:22th Nov 2020
Published:22th Nov 2020
Condition: Liposarcoma
Type: drug
Register free for full access to medthority.com